Affordable Eribulin Mesylate 0.5 mg/mL Injection – Quality Oncology Medicine Supplier
Eribulin Mesylate 0.5 mg/mL Injection is a specialized oncology medicine used in the treatment of certain advanced cancers, including metastatic breast cancer and unresectable or metastatic liposarcoma, as prescribed by qualified healthcare professionals.
Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical manufacturer and exporter from India, providing quality oncology injectable medicines at competitive prices for hospitals, cancer care centers, pharmaceutical distributors, wholesalers, and authorized personal importers.
Product Details
- Product Name: Eribulin Mesylate Injection
- Strength: 0.5 mg/mL
- Dosage Form: Sterile Injectable
- Administration: Intravenous (IV)
- Therapeutic Category: Oncology Medicine
- Manufacturer: Cordium Pharmaceuticals Pvt Ltd
Affordable Eribulin Mesylate Injection Supply for Global Buyers
Cordium Pharmaceuticals supports healthcare organizations looking for reliable and cost-effective oncology medicine solutions.
Hospitals & Cancer Centers
We provide supply support for hospitals and oncology institutions requiring dependable access to injectable cancer medicines.
Pharma Distributors & Wholesalers
We collaborate with licensed distributors and pharmaceutical importers seeking competitive pricing and long-term supply partnerships.
Personal Import
Patients and caregivers looking for personal import options should follow their country's regulations and obtain medicines through authorized healthcare channels with proper documentation.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharma focuses on delivering quality, affordability, and reliability in pharmaceutical exports.
Key Benefits:
✔ Competitive pricing for bulk requirements
✔ Quality-focused manufacturing standards
✔ Reliable oncology product supply
✔ Export documentation assistance
✔ Support for international buyers
✔ Professional customer service
✔ Strong pharmaceutical export experience
✔ Long-term partnership approach
Global Pharmaceutical Supply Partner
Cordium Pharmaceuticals Pvt Ltd works with qualified buyers across international markets, supporting:
- Hospitals
- Oncology clinics
- Pharmaceutical distributors
- Importers
- Healthcare organizations
- Institutional procurement teams
Supply is subject to country-specific regulatory requirements and import regulations.
Frequently Asked Questions (FAQs)
1. What is Eribulin Mesylate 0.5 mg/mL Injection used for?
Eribulin Mesylate Injection is an oncology medicine prescribed for certain patients with metastatic breast cancer and unresectable or metastatic liposarcoma according to approved medical guidelines.
2. Who can purchase Eribulin Mesylate Injection?
Hospitals, oncology centers, licensed pharmaceutical distributors, wholesalers, and authorized importers can procure the product according to applicable regulations.
3. Does Cordium Pharmaceuticals provide affordable pricing?
Yes, Cordium Pharmaceuticals offers competitive commercial pricing based on order quantity, destination, and buyer requirements.
4. Can patients import Eribulin Mesylate Injection personally?
Personal import rules vary by country. Patients should consult healthcare professionals and follow local import regulations before purchasing.
5. Why choose Cordium Pharmaceuticals for oncology medicines?
Cordium Pharma provides quality-focused manufacturing, reliable supply support, competitive pricing, and professional assistance for global pharmaceutical partners.
Contact Cordium Pharmaceuticals Pvt Ltd
For affordable supply of Eribulin Mesylate 0.5 mg/mL Injection, hospitals, pharmaceutical distributors, and authorized importers can connect with Cordium Pharmaceuticals Pvt Ltd for commercial inquiries and supply solutions.